PT-141 (10MG)

PT-141 is a well-characterized synthetic peptide analog employed in laboratory research to investigate melanocortin receptor binding, peptide–receptor dynamics, and intracellular signaling mechanisms. Its defined cyclic peptide structure allows precise in vitro evaluation. The lyophilized format ensures stability, reproducibility, and integrity for non-clinical research studies.
Research Applications
PT-141 is suitable for in vitro studies including:
Analysis of melanocortin receptor binding and signaling pathways
Investigation of peptide–receptor interaction dynamics in melanocortin system models
Evaluation of intracellular signaling cascades associated with peptide ligands
Study of structure-function relationships of cyclic peptide analogs
Stability, degradation, and analytical profiling in assay-based systems
Storage and Handling
Store lyophilized powder at −20°C (−4°F)
After reconstitution, maintain at 2–8°C (36–46°F) and use promptly
Avoid repeated freeze-thaw cycles
Follow aseptic techniques during laboratory handling
Product Specifications
Purity: ≥99% (HPLC Certified)
Appearance: White lyophilized powder
Solubility: Soluble in appropriate laboratory solvents
Compliance Notice
For research use only as an analytical reference material. PT-141 is the active ingredient of the FDA-approved drug Vyleesi®. This research material is not the approved pharmaceutical product, is not intended for human or veterinary use, and has not been independently evaluated by the FDA for research purposes. Buyers are solely responsible for determining the legal status of this compound in their jurisdiction, including compliance with the Federal Analog Act (21 U.S.C. § 813) and applicable state laws. Misuse is strictly prohibited and may violate federal, state, or local regulations. By purchasing, the buyer confirms use strictly for in vitro research purposes.